X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1903) 1903
animals (1798) 1798
mecamylamine - pharmacology (1578) 1578
male (1281) 1281
rats (1166) 1166
mecamylamine (852) 852
neurosciences (793) 793
pharmacology & pharmacy (765) 765
nicotine - pharmacology (764) 764
nicotinic antagonists - pharmacology (713) 713
nicotine (666) 666
dose-response relationship, drug (505) 505
female (390) 390
mice (378) 378
rats, sprague-dawley (375) 375
nicotinic agonists - pharmacology (344) 344
atropine - pharmacology (331) 331
receptors, nicotinic - drug effects (296) 296
acetylcholine (294) 294
psychiatry (275) 275
humans (269) 269
receptors, nicotinic - metabolism (261) 261
rats, wistar (242) 242
rat (218) 218
brain (217) 217
receptors, nicotinic - physiology (208) 208
nicotine - administration & dosage (191) 191
time factors (188) 188
receptors (187) 187
in vitro techniques (176) 176
acetylcholine-receptors (174) 174
behavior, animal - drug effects (173) 173
acetylcholine - pharmacology (167) 167
neurons (162) 162
dopamine (156) 156
muscarinic antagonists - pharmacology (155) 155
article (153) 153
behavioral sciences (152) 152
neurons - drug effects (151) 151
blood pressure - drug effects (150) 150
motor activity - drug effects (150) 150
drug interactions (147) 147
hexamethonium compounds - pharmacology (143) 143
alzheimers-disease (132) 132
ventral tegmental area (131) 131
nucleus-accumbens (126) 126
dopamine - metabolism (123) 123
nicotine - antagonists & inhibitors (123) 123
smoking (122) 122
scopolamine (121) 121
rats, inbred strains (118) 118
physostigmine - pharmacology (116) 116
brain - drug effects (113) 113
mecamylamine - administration & dosage (112) 112
release (112) 112
analysis of variance (110) 110
cats (110) 110
rodents (109) 109
scopolamine hydrobromide - pharmacology (109) 109
electric stimulation (106) 106
physiology (106) 106
heart rate - drug effects (103) 103
memory (103) 103
pharmacology (100) 100
mice, inbred c57bl (99) 99
acetylcholine - metabolism (98) 98
nicotinic receptors (97) 97
dihydro-beta-erythroidine - pharmacology (94) 94
acetylcholine receptors (91) 91
reinforcement (91) 91
scopolamine - pharmacology (91) 91
biomedicine (88) 88
reward (88) 88
conditioning, operant - drug effects (87) 87
brain - metabolism (86) 86
microdialysis (85) 85
adult (82) 82
cigarette-smoking (82) 82
disease models, animal (81) 81
atropine (80) 80
pharmacology/toxicology (80) 80
nicotinic acetylcholine receptor (77) 77
hippocampus (76) 76
hippocampus - drug effects (76) 76
research (76) 76
analysis (75) 75
receptors, muscarinic - drug effects (75) 75
withdrawal (75) 75
biochemistry & molecular biology (74) 74
cells, cultured (74) 74
carbachol - pharmacology (72) 72
nicotinic antagonists - administration & dosage (71) 71
antagonist (70) 70
cholinesterase inhibitors - pharmacology (70) 70
neurons - metabolism (70) 70
nicotinic acetylcholine-receptors (70) 70
nicotinic receptor (70) 70
rat-brain (70) 70
addiction (69) 69
nicotinic (69) 69
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2101) 2101
Japanese (11) 11
French (7) 7
Italian (4) 4
Russian (4) 4
Chinese (2) 2
German (2) 2
Spanish (2) 2
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Psychopharmacology, ISSN 0033-3158, 5/2014, Volume 231, Issue 9, pp. 1975 - 1985
Neuronal nicotinic acetylcholine receptors (nAChRs) play a modulatory role in cognition, and zebrafish provide a preclinical model to study learning and... 
Neurosciences | α-Conotoxin | Scopolamine | Neuronal nicotinic receptors | Zebrafish | Cholinergic system | Methyllycaconitine | Mecamylamine | Biomedicine | Dihydro-β-erythroidine | Pharmacology/Toxicology | T-maze | Psychiatry | Spatial memory | Dihydro-beta-erythroidine | DANIO-RERIO | TASK | CHOLINERGIC CHANNEL ACTIVATOR | PSYCHIATRY | BEHAVIOR | INVOLVEMENT | Spatialmemory | SYNAPTIC PLASTICITY | NEUROSCIENCES | COGNITIVE FUNCTION | SELECTIVE STIMULATION | PARTIAL AGONIST | PHARMACOLOGY & PHARMACY | alpha-Conotoxin | WORKING-MEMORY | Memory - drug effects | Cholinergic Agents - pharmacology | Dihydro-beta-Erythroidine - pharmacology | Nicotinic Antagonists - pharmacology | Nicotine - pharmacology | Dose-Response Relationship, Drug | Scopolamine Hydrobromide - pharmacology | Muscarinic Antagonists - pharmacology | Mecamylamine - pharmacology | Neurons - physiology | Swimming | Neurons - drug effects | Nicotinic Agonists - pharmacology | Azocines - chemistry | Receptors, Nicotinic - metabolism | Alkaloids - pharmacology | Maze Learning - physiology | Zebrafish Proteins - metabolism | Quinolizines - pharmacology | Aconitine - analogs & derivatives | Aconitine - pharmacology | Maze Learning - drug effects | Conotoxins - pharmacology | Animals | Nicotinic Antagonists - chemistry | Zebrafish - physiology | Azocines - pharmacology | Alkaloids - chemistry | Quinolizines - chemistry | Memory - physiology | Learning | Receptors | Memory | Zebra fish | Physiological aspects | Genetic aspects | Acetylcholine | Research | Fish | Psychopharmacology | Animal memory | Index Medicus
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 02/2011, Volume 36, Issue 3, pp. 589 - 602
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2008, Volume 28, Issue 14, pp. 3769 - 3780
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 807 - 816
Accumulating evidence suggests that acetylcholine nicotinic systems may contribute importantly to the abuse-related effects of d-methamphetamine (d-MA). The... 
DIHYDRO-BETA-ERYTHROIDINE | ACETYLCHOLINE-RECEPTORS | SQUIRREL-MONKEYS | DOPAMINE RELEASE | BEHAVIORAL SENSITIZATION | PHARMACOLOGY & PHARMACY | MONOAMINE TRANSPORTERS | STIMULUS PROPERTIES | ALPHA-BUNGAROTOXIN | NUCLEUS-ACCUMBENS | UPTAKE INHIBITORS | Nicotinic Antagonists - administration & dosage | Cholinergic Agents - administration & dosage | Cholinergic Agents - pharmacology | Varenicline | Pentobarbital - administration & dosage | Pentobarbital - pharmacology | Male | Nicotinic Antagonists - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Drug Interactions | Muscarinic Antagonists - pharmacology | Discrimination (Psychology) | Mecamylamine - pharmacology | Behavior, Animal - drug effects | Nicotinic Agonists - pharmacology | Discrimination Learning | Methamphetamine - pharmacology | Dopamine Agonists - pharmacology | Mecamylamine - administration & dosage | Dextroamphetamine - pharmacology | Quinoxalines - administration & dosage | Reinforcement (Psychology) | Rats | Benzazepines - pharmacology | Rats, Sprague-Dawley | Muscarinic Antagonists - administration & dosage | Nicotinic Agonists - administration & dosage | Animals | Cholinesterase Inhibitors - administration & dosage | Cholinesterase Inhibitors - pharmacology | Methamphetamine - administration & dosage | Dopamine Agonists - administration & dosage | Conditioning, Operant | Benzazepines - administration & dosage | Dextroamphetamine - administration & dosage | Index Medicus | Behavioral Pharmacology
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 7/2013, Volume 228, Issue 2, pp. 321 - 333
Receptor mechanisms underlying the behavioral effects of clinically used nicotinic acetylcholine receptor agonists have not been fully established.Drug... 
Drug discrimination | Neurosciences | Agonist | Varenicline | Cytisine | Efficacy | Mecamylamine | Biomedicine | Mouse | Antagonist | Dihydro-β-erythroidine | Pharmacology/Toxicology | Psychiatry | Nicotine | Dihydro-beta-erythroidine | PSYCHIATRY | PHARMACOLOGICAL CHARACTERIZATION | RATS | RECEPTOR PARTIAL AGONIST | NEUROSCIENCES | ACETYLCHOLINE-RECEPTORS | MU OPIOIDS | PHARMACOLOGY & PHARMACY | DISCRIMINATIVE STIMULUS PROPERTIES | ALPHA-4-BETA-2 | Nicotine - administration & dosage | Dihydro-beta-Erythroidine - pharmacology | Male | Nicotine - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Discrimination Learning - drug effects | Tobacco Use Cessation Products | Mecamylamine - pharmacology | Nicotinic Agonists - pharmacology | Quinolizines - administration & dosage | Receptors, Nicotinic - drug effects | Receptors, Nicotinic - metabolism | Alkaloids - pharmacology | Morphine - pharmacology | Quinoxalines - administration & dosage | Mice, Inbred C57BL | Quinolizines - pharmacology | Benzazepines - pharmacology | Smoking Cessation - methods | Nicotinic Agonists - administration & dosage | Animals | Alkaloids - administration & dosage | Azocines - pharmacology | Benzazepines - administration & dosage | Mice | Azocines - administration & dosage | Midazolam - pharmacology | Smoking cessation programs | Dosage and administration | Health aspects | Smoking cessation | Pharmacology | Rodents | Index Medicus | dihydro-β-erythroidine | mecamylamine | varenicline | mouse | nicotine | drug discrimination | agonist | antagonist | cytisine | efficacy
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 04/2011, Volume 36, Issue 5, pp. 1021 - 1032
Nicotine activation of nicotinic acetylcholine receptors (nAChRs) within the dopaminergic (DAergic) neuron-rich ventral tegmental area (VTA) is necessary and... 
nicotine | acetylcholine | ventral tegmental area | dopamine | mice | smoking | PSYCHIATRY | REWARD | NEUROSCIENCES | NUCLEUS-ACCUMBENS | POSTERIOR | ACETYLCHOLINE-RECEPTORS | CIGARETTE-SMOKING | MUTANT MICE | SYNAPTIC MECHANISMS | ETHANOL | PHARMACOLOGY & PHARMACY | ALPHA-CONOTOXIN-MII | MIDBRAIN | Tyrosine 3-Monooxygenase - metabolism | Temperature | Male | Nicotinic Antagonists - pharmacology | Ventral Tegmental Area - cytology | RNA, Messenger - metabolism | Patch-Clamp Techniques - methods | Nicotine - pharmacology | Drug Interactions | Muscarinic Antagonists - pharmacology | Mecamylamine - pharmacology | 6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology | Receptors, Nicotinic - deficiency | Neurons - metabolism | Neurons - drug effects | Electric Stimulation - methods | Action Potentials - drug effects | Dopamine - metabolism | Nicotinic Agonists - pharmacology | GABA-A Receptor Antagonists - pharmacology | Receptors, Nicotinic - metabolism | Gene Expression Regulation - genetics | Cell Size - drug effects | Mice, Inbred C57BL | Proto-Oncogene Proteins c-fos - metabolism | Atropine - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Bicuculline - pharmacology | Mice, Knockout | Gene Expression Regulation - drug effects | Microdissection - methods | Animals | Cell Count - methods | Analysis of Variance | Mice | In Vitro Techniques | Receptors, Nicotinic - genetics | Index Medicus | addiction & substance abuse | neurophysiology | Original
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2006, Volume 540, Issue 1, pp. 96 - 106
Male Wistar rats were trained to discriminate (−)-nicotine (0.4 mg/kg) from saline under a two-lever, fixed-ratio 10 schedule of water reinforcement. During... 
Drug discrimination | Rat | Nicotinic acetylcholine receptor | Cannabinoid system | Nicotine | nicotine | DIHYDRO-BETA-ERYTHROIDINE | rat | ANTAGONIST SR141716A | BEHAVIOR | PLACE PREFERENCES | ANANDAMIDE TRANSPORT | drug discrimination | AFFINITY | PHARMACOLOGY & PHARMACY | cannabinoid system | MEDIATED RESPONSES | XENOPUS OOCYTES | BRAIN | nicotinic acetylcholine receptor | AGONIST | Receptor, Cannabinoid, CB2 - physiology | Rats, Wistar | Cannabinoid Receptor Antagonists | Dihydro-beta-Erythroidine - pharmacology | Bornanes - pharmacology | Receptors, Cannabinoid - physiology | Male | Nicotinic Antagonists - pharmacology | Azetidines - pharmacology | Benzoxazines | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - physiology | Nicotine - pharmacology | Dose-Response Relationship, Drug | Discrimination Learning - drug effects | Mecamylamine - pharmacology | Benzamides - pharmacology | Cyclohexanols - pharmacology | Endocannabinoids | Nicotinic Agonists - pharmacology | Carbamates - pharmacology | Pyrazoles - pharmacology | Morpholines - pharmacology | Rats | Aconitine - analogs & derivatives | Aconitine - pharmacology | Arachidonic Acids - pharmacology | Discrimination Learning - physiology | Naphthalenes - pharmacology | Drug Synergism | Animals | Receptors, Nicotinic - physiology | Polyunsaturated Alkamides - pharmacology | Pyridines - pharmacology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Enzymes | Pyridine | Hydrolases | Drug therapy, Combination | Cyclohexanol | Fatty acids | Index Medicus
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 09/2014, Volume 25, Issue 5 and 6, pp. 518 - 531
Journal Article